DDX39B and colorectal carcinoma: In our previous study, we have confirmed that DDX39B can upregulate the expression of FUT3 through the aberrant AS and then promoting the fucosylation of TGFβR-I, which subsequently enhances activation of the TGFβ/SMAD2 signaling pathway to facilitate the invasion and metastasis of CRC [22].